Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Exercise × 1 year × Clear all

Sponsor

Conditions

Motor Activity 46 Breast Neoplasms 27 Neoplasms 17 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Obesity 6 Lymphedema 5 Colonic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Hematologic Neoplasms 4 Fatigue 4 Endometrial Neoplasms 4 Brain Neoplasms 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Lymphoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Peripheral Nervous System Diseases 2 Overweight 2 Neoplasm Metastasis 2 Melanoma 2 Medulloblastoma 2 Malnutrition 2

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡